Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by LVW Advisors LLC

LVW Advisors LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,448 shares of the medical equipment provider’s stock after acquiring an additional 19 shares during the quarter. LVW Advisors LLC’s holdings in Intuitive Surgical were worth $756,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the third quarter valued at approximately $38,000. Finally, DT Investment Partners LLC raised its stake in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on ISRG. Royal Bank of Canada upped their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Piper Sandler restated an “overweight” rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial upped their price objective on Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Raymond James increased their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $592.64 on Monday. The stock has a fifty day moving average price of $540.66 and a two-hundred day moving average price of $499.19. The firm has a market cap of $211.09 billion, a P/E ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.